BAG3 and mesothelioma: Indeed, the analysis of PDXs databases allowed us to circumscribe and easier identify HNSCC, mesothelioma, and liver hepatocellular cancer as the fibrotic tumors presumably more responsive to the anti‐BAG3 therapy, due to the higher bag3 expression levels that negatively correlate with patient survival.